<DOC>
	<DOCNO>NCT02037880</DOCNO>
	<brief_summary>The purpose study ass rate decline motor cognitive functional measure , assess potential biomarkers , order identify potential outcome measure appropriate use therapeutic clinical trial .</brief_summary>
	<brief_title>Natural History Studies Mucopolysaccharidosis III</brief_title>
	<detailed_description>Mucopolysaccharidosis ( MPS ) type III ( Sanfilippo syndrome ) group four devastate genetic disease result abnormal accumulation glycosaminoglycans body tissue . In MPSIII predominant symptom occur due accumulation within central nervous system ( CNS ) , include brain spinal cord , result cognitive decline , motor dysfunction , eventual death . In anticipation future therapeutic study MPSIIIA MPSIIIB , perform natural history study identify follow : 1 . Individual rate decline motor cognitive function cohort potential clinical trial patient 2 . The natural history outcome measure order ass appropriateness outcomes eventual trial 3 . Baseline functional data patient potential candidate eventual trial 4 . Biomarkers disease progression 12-month interval , include change brain MRI cerebrospinal fluid Patients study need come Nationwide Children 's Hospital Columbus , Ohio , three time . At three time point , cognitive outcome measure assess : baseline ( visit 1 ) , 6 month ( visit 2 ) , 12 month ( visit 3 ) . At baseline ( visit 1 ) 12 month ( visit 3 ) , MRI lumbar puncture perform .</detailed_description>
	<mesh_term>Mucopolysaccharidoses</mesh_term>
	<mesh_term>Mucopolysaccharidosis III</mesh_term>
	<criteria>1 . Age 2 year old great 2 . Confirmed diagnosis MPSIIIA MPSIIIB either two method : 1 . No detectable significantly reduce NAGLU ( MPSIIIB ) SGSH ( MPSIIIA ) activity serum leukocyte assay 2 . Genomic DNA mutation analysis demonstrate homozygous compound heterozygous mutation NAGLU ( MPSIIIB ) SGSH ( MPSIIIA ) gene 3 . Clinical history examination feature neurologic dysfunction . 1 . Inability participate clinical evaluation 2 . Presence concomitant medical condition precludes lumbar puncture use anesthetic 3 . Inability safely sedate opinion clinical anesthesiologist</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Mucopolysaccharidosis</keyword>
	<keyword>MPS</keyword>
	<keyword>Sanfilippo</keyword>
</DOC>